ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: iPSCs generated from imatinib-sensitive chronic myelogenous leukemia (CML) patients showed imatinib insensitivity despite restored the expression of the BCR-ABL oncoprotein.